These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17314615)

  • 21. The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: relation to histologic subtypes based on the World Health Organization classification.
    Tsukamoto N; Kojima M; Hasegawa M; Oriuchi N; Matsushima T; Yokohama A; Saitoh T; Handa H; Endo K; Murakami H
    Cancer; 2007 Aug; 110(3):652-9. PubMed ID: 17582800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [(18)F]FDG in childhood lymphoma: clinical utility and impact on management.
    Montravers F; McNamara D; Landman-Parker J; Grahek D; Kerrou K; Younsi N; Wioland M; Leverger G; Talbot JN
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1155-65. PubMed ID: 12192560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of FDG-PET in diagnosing primary lymphoma of the liver.
    Bangerter M; Moog F; Griesshammer M; Merkle E; Hafner M; Ellenrieder V; Reske SN; Heimpel H
    Int J Hematol; 1997 Dec; 66(4):517-20. PubMed ID: 9479878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDG PET imaging in patients with lymphoma: a clinical perspective.
    Segall GM
    J Nucl Med; 2001 Apr; 42(4):609-10. PubMed ID: 11337550
    [No Abstract]   [Full Text] [Related]  

  • 25. Peripheral nerves and muscles involvement by non-Hodgkin's lymphoma seen on FDG PET/CT scan.
    Shah HJ; Lele VR; Keraliya AR; Aland PS
    Neurol India; 2014; 62(1):83-5. PubMed ID: 24608470
    [No Abstract]   [Full Text] [Related]  

  • 26. [FDG-PET on the day after first chemotherapy in malignant lymphoma].
    Yamane T; Daimaru O; Itoh S; Nagata T; Yoshiya K; Itoh S; Uchida H; Shinai T; Imai T; Ohishi H
    Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Dec; 62(14):839-42. PubMed ID: 12607955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary non-Hodgkin's lymphoma of bone arising from hip.
    Lamichhane A; Mahara D
    J Nepal Health Res Counc; 2013 Jan; 11(23):89-91. PubMed ID: 23787536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma].
    Thill R; Neuerburg J; Fabry U; Cremerius U; Wagenknecht G; Hellwig D; Osieka R; Günther R; Büll U
    Nuklearmedizin; 1997 Oct; 36(7):234-9. PubMed ID: 9441282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma.
    Moog F; Kotzerke J; Reske SN
    J Nucl Med; 1999 Sep; 40(9):1407-13. PubMed ID: 10492357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.
    Kostakoglu L; Coleman M; Leonard JP; Kuji I; Zoe H; Goldsmith SJ
    J Nucl Med; 2002 Aug; 43(8):1018-27. PubMed ID: 12163626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].
    Bumann D; de Wit M; Beyer W; Beese M; Lübeck M; Bücheler E; Clausen M
    Rofo; 1998 May; 168(5):457-65. PubMed ID: 9617362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
    Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
    Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of FDG positron emission tomography imaging on the management of lymphomas.
    Shah N; Hoskin P; McMillan A; Gibson P; Lowe J; wong WL
    Br J Radiol; 2000 May; 73(869):482-7. PubMed ID: 10884743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical thoracic and supraclavicular FDG-uptake in patients with Hodgkin's and non-Hodgkin's lymphoma.
    Döbert N; Menzel C; Hamscho N; Wördehoff W; Kranert WT; Grünwald F
    Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):33-8. PubMed ID: 15195002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-FDG PET in non-Hodgkin's lymphoma: qualitative or quantitative?
    Weber WA
    J Nucl Med; 2007 Oct; 48(10):1580-2. PubMed ID: 17909256
    [No Abstract]   [Full Text] [Related]  

  • 36. Positron emission tomography using F-18 fluorodeoxyglucose pre- and post-autologous stem cell transplant in non-Hodgkin's lymphoma.
    Johnston PB; Wiseman GA; Micallef IN
    Bone Marrow Transplant; 2008 Jun; 41(11):919-25. PubMed ID: 18391991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hodgkin's and non-Hodgkin's lymphomas.
    Rademaker J
    Radiol Clin North Am; 2007 Jan; 45(1):69-83. PubMed ID: 17157624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma.
    Bodet-Milin C; Kraeber-Bodéré F; Moreau P; Campion L; Dupas B; Le Gouill S
    Haematologica; 2008 Mar; 93(3):471-2. PubMed ID: 18310543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fortuitous detection of papillary carcinoma of the thyroid with F-18 FDG positron emission tomography in a patient with non-Hodgkin lymphoma.
    Kim CE; Joyce JM; Patel N; Lichter J
    Clin Nucl Med; 2003 Sep; 28(9):782-3. PubMed ID: 12973010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-Fluorodeoxyglucose PET in a patient with primary small bowel lymphoma: the only sensitive method of imaging.
    Ullerich H; Franzius CH; Domagk D; Seidel M; Sciuk J; Schober ; Domschke W
    Am J Gastroenterol; 2001 Aug; 96(8):2497-9. PubMed ID: 11513199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.